Research

Vitamin K2 and D May be Beneficial in Coronary Artery Calcification

In a study of 304 participants, those with no prior ischemic heart disease saw significantly slowed CAC scores compared to placebo over two years.

Products & Ingredients

Probiotix Health Launches New Heart Health Supplement CholBiome

The formulation contains Lactobacillus plantarum LPLDL, K2Vital Delta from Kappa Bioscience, and thiamine, a form of vitamin B1 with an EFSA heart health claim.

VideoBites

Balchem Discusses Growth Trajectory for Portfolio of Specialty Ingredients in Key Markets

The company has bolstered its human nutrition and health unit with several strategic M&As.

Features

Health Benefits of Vitamin K: A Contemporary Cornerstone of Heart and Bone Health

Clinical research is revealing overlooked health benefits of the micronutrient.

Research

Vitamins K and D May Play Protective Role in Coronary Artery Calcification

Emerging science shows that vitamin K2 and D supplementation play an important role in heart health.

Products & Ingredients

Balchem Agrees to Acquire Kappa Bioscience AS

The vitamin K2 supplier was purchased from majority owner Verdane Edda for approximately $338 million.

Products & Ingredients

Kappa BioScience Forms Scientific and Medical Advisory Board

The team of leading academics in cardiology, immunology, kinesiology, and molecular nutrition have authored over 700 scientific papers.

Exclusives

ICYMI: What People Were Reading on NutraceuticalsWorld.com in January 2022

Here's what people were reading online last month.

Features

Vitamin and Mineral Supplements Offer A Sturdy Industry Foundation

Dialing up the performance and personalization of formulations remains a key focus when it comes to mainstream micronutrients.

Research

Vitamin K Status May Have Stronger Impact on COVID-19 Than Vitamin D Deficiency

A new study supported by Kappa Bioscience concludes that D supplementation should be complemented with vitamin K2.

Research

Deficiencies in Vitamins D and K Independently Linked to COVID-19 Severity

A new study supported by Kappa Bioscience showed that these two vitamins could play independent roles in the disease’s pathogenesis.

Research

Deficiencies in Vitamin K2 or Vitamin D Associated with Poor COVID-19 Outcomes

Findings will inform further investigations and implications for inflammation among COVID-19 patients, researchers said.

Research

New Study Backs Early Evidence of Association Between Low Vitamin K and COVID-19 Severity

Backed by Kappa Bioscience, the study found hospitalized patients with low vitamin K were more likely than on average to have low vitamin K status.

Research

Kappa Bioscience Extends Research Partnership For COVID-19 Research

The sponsored research will be the first clinical trial to explore vitamin K2 supplementation in COVID-19 patients.

Research

Review Calls for Research on Vitamin K Metabolism and COVID-19

Clinical evidence suggests the micronutrient’s anticoagulation effect may be beneficial in cardiovascular outcomes related to COVID-19 infection.